David Ricks, Eli Lilly CEO (Paulo Nunes dos Santos/Bloomberg via Getty Images)
February 26, 2025 09:30 AM ESTUpdated 03:09 PM
Manufacturing

Up­dat­ed: Lil­ly joins Trump ad­min­is­tra­tion to an­nounce $27B man­u­fac­tur­ing com­mit­ment

Zachary Brennan

Senior Editor

WASH­ING­TON — Eli Lil­ly tout­ed a huge new US man­u­fac­tur­ing in­vest­ment at an event on Wednes­day, trot­ting out the news with a mem­ber of Pres­i­dent Don­ald …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

As­traZeneca’s SERD hits pri­ma­ry end­point in late-stage tri­al, but first-line po­ten­tial re­mains un­cer­tain

Eikon Ther­a­peu­tics rais­es $351M Se­ries D as lead drug starts Phase 3

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Re­gen­eron, two Chi­nese biotechs tout promise of their hear­ing loss gene ther­a­pies

Har­bour Bio­Med inks deal up to $395M; ORIC re­fines plans for two drugs

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times